The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Siemens' revenue will compress 6.6% and EPS will grow 77.6%.
The average estimate for revenue is $24.19 billion. On the bottom line, the average EPS estimate is $2.06.
Last quarter, Siemens chalked up revenue of $25.73 billion. GAAP reported sales were 2.4% higher than the prior-year quarter's $25.13 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.53. GAAP EPS of $1.48 for Q2 were 67% lower than the prior-year quarter's $4.49 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 28.9%, 230 basis points worse than the prior-year quarter. Operating margin was 10.2%, 140 basis points worse than the prior-year quarter. Net margin was 5.1%, 1,070 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $93.72 billion. The average EPS estimate is $8.35.
The stock has a five-star rating (out of five) at Motley Fool CAPS. Among 187 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 180 give Siemens a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Siemens is outperform, with an average price target of $114.35.
- Add Siemens to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.